Serial Number:
90430250
Mark:
NUGALVIQ
Status:
Fifth Extension-Granted
Status Date:
03-22-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Mark Description:
N/A
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
08-10-2021
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
HOGAN LOVELLS US LLP
Correspondent Name:
